A detailed history of Rafferty Asset Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 48,246 shares of ZTS stock, worth $7.99 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
48,246
Previous 51,993 7.21%
Holding current value
$7.99 Million
Previous $9.01 Million 4.58%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $646,657 - $736,210
-3,747 Reduced 7.21%
48,246 $9.43 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $265,756 - $326,543
1,826 Added 3.64%
51,993 $9.01 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $200,295 - $241,727
1,209 Added 2.47%
50,167 $8.49 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $159,163 - $210,294
-1,051 Reduced 2.1%
48,958 $9.66 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $548,052 - $632,092
3,279 Added 7.02%
50,009 $8.7 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $548,000 - $634,113
3,405 Added 7.86%
46,730 $8.05 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $186,941 - $224,900
1,285 Added 3.06%
43,325 $7.21 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $2.04 Million - $2.44 Million
15,523 Added 58.54%
42,040 $6.16 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $2.02 Million - $2.49 Million
13,630 Added 105.77%
26,517 $3.93 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $613,430 - $786,953
-3,933 Reduced 23.38%
12,887 $2.22 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $512,426 - $661,134
-2,825 Reduced 14.38%
16,820 $3.17 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $161,150 - $205,528
832 Added 4.42%
19,645 $4.79 Million
Q3 2021

Nov 10, 2021

BUY
$189.29 - $209.69 $947,017 - $1.05 Million
5,003 Added 36.23%
18,813 $3.65 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $289,506 - $349,097
1,857 Added 15.54%
13,810 $2.57 Million
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $47,376 - $55,729
329 Added 2.83%
11,953 $1.88 Million
Q4 2020

Feb 10, 2021

BUY
$157.07 - $174.35 $103,823 - $115,245
661 Added 6.03%
11,624 $1.92 Million
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $266,933 - $321,975
-1,947 Reduced 15.08%
10,963 $1.81 Million
Q2 2020

Aug 07, 2020

BUY
$111.92 - $142.53 $910,021 - $1.16 Million
8,131 Added 170.14%
12,910 $1.77 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $1.05 Million - $1.65 Million
-11,358 Reduced 70.38%
4,779 $562,000
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $1.29 Million - $1.48 Million
11,094 Added 219.99%
16,137 $2.14 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $567,690 - $647,672
5,043 New
5,043 $628,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.